发明名称 Tetrameric streptavidin mutein with reversible biotin binding capability
摘要 The present invention relates to a new streptavidin muteins. This mutein is The muteins are capable of oligomerization to form tetramers, with relatively strong subunit interactions, dissociation constant (KD) for biotin in this mutein in the range of 10−7 to 10−8M, off-rate (koff) for the bound biotin in the streptavidin-biotin complex in the range of 10−4 sec−1, stable enough to allow reuse, and producible producable with reasonable production yield via secretion in a soluble functional state without the requirement of refolding streptavidin via the tedious and expensive denaturation and renaturation processes.
申请公布号 US8822640(B2) 申请公布日期 2014.09.02
申请号 US201113272922 申请日期 2011.10.13
申请人 UTI Limited Partnership 发明人 Wong Sui-Lam;Wu Sau-Ching;Barrette-Ng Isabelle;Ng Ken
分类号 C07K14/36;C12N15/31;C07K1/22;C07K14/32 主分类号 C07K14/36
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A streptavidin mutein comprising the sequence Asp-Ser-Ser-Asn-Gly-Ser-Asp-Gly (SEQ ID NO: 11) at positions 114-121 corresponding to full-length wild-type streptavidin (SEQ ID NO:1).
地址 Calgary CA